Brendan G Dwyer

10PUBLICATIONS
70CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsBiologically active moleculesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

|Jan 26, 2026
Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability.

Michal Sekrecki, Agata Sekrecka, Rohan R Lattupally

|Jan 02, 2026
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy.

Tian Qiu, Yeuan Ting Lee, Brendan G Dwyer

|Dec 02, 2025
Selective CDK6 Degradation via the KLHDC2 E3 Ubiquitin Ligase.

Eunhye Jeon, Younghoon Kim, Hyunwoo Ahn

|Nov 27, 2025
Rewiring the Fusion Oncoprotein EWSR1::FLI1 in Ewing Sarcoma with Bivalent Small Molecules.

Michael J Bond, Ryan P Golden, Giulia DiGiovanni

|Nov 24, 2025
Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy.

Tian Qiu, Yeuan Ting Lee, Brendan G Dwyer

Pageof 2

Frequent Collaborators

10 joint publications

Nathanael S Gray

8 joint publications

Stephen M Hinshaw

5 joint publications

Gerald R Crabtree

5 joint publications

Tinghu Zhang